Irritable Bowel Syndrome (IBS) Treatment Growth Forecast 2025-2034: Trends, Opportunities, and Key Insights You Need to Know
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What is the Predicted CAGR for the Irritable Bowel Syndrome (IBS) Treatment Market Over the Forecast Period of 2025 to 2034?
The irritable bowel syndrome (IBS) treatment market has grown rapidly, with an expected increase from $2.79 billion in 2024 to $3.07 billion in 2025, reflecting a CAGR of 10.2%. Historical growth factors include the increasing prevalence of IBS, heightened patient awareness, the influence of stress and lifestyle changes, the role of patient advocacy and support groups, and evolving healthcare reimbursement policies.
The irritable bowel syndrome (IBS) treatment market is forecasted to grow rapidly, reaching $4.93 billion by 2029 with a CAGR of 12.5%. Growth drivers include patient-focused healthcare models, advances in microbial therapies, blockchain adoption in healthcare, increased patient-reported outcomes (PROs), regulatory fast-track programs, and enhanced health data interoperability. Key trends include digital health integration, diagnostic technology advancements, increased R&D investments, strategic collaborations, and non-pharmacological treatment innovations.
Which Drivers Are Expected to Have the Greatest Impact on the irritable bowel syndrome (ibs) treatment Market’s Growth?
The increasing prevalence of irritable bowel syndrome (IBS) is expected to fuel the growth of the IBS treatment market. IBS, a chronic gastrointestinal condition, is influenced by poor lifestyle choices, bad eating habits, pollution, and stress. Treatments for IBS help manage symptoms and improve quality of life. According to the International Foundation for Gastrointestinal Disorders (IFFGD), in 2023, 5-10% of the global population has IBS, with 25-45 million affected in the U.S. Therefore, the growing prevalence of IBS is driving the IBS treatment market’s growth.
Get Your Free Sample of the Global Irritable Bowel Syndrome (IBS) Treatment Market Report Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11978&type=smp
Who Are the Top Companies Driving Innovation and Growth in the Irritable Bowel Syndrome (IBS) Treatment Market?
Major companies operating in the irritable bowel syndrome (IBS) treatment market include:
• Pfizer Inc._x000D_
• Johnson & Johnson Services Inc._x000D_
• AbbVie Inc._x000D_
• Novartis AG_x000D_
• AstraZeneca plc_x000D_
What Key Trends Are Currently Impacting the Irritable Bowel Syndrome (IBS) Treatment Market’s Development?
Product innovations are gaining momentum in the irritable bowel syndrome (IBS) market. Leading IBS market players are focused on creating new, advanced products to secure their position. For example, in April 2022, Ardelyx, a US-based biotechnology company, launched IBSRELA, the first NHE3 inhibitor for IBS-C treatment in adults. It is the only FDA-approved therapy for IBS-C, offering a novel treatment for constipation, bloating, and stomach pain, addressing a need for effective therapies in the IBS market after nearly a decade of no new treatment options.
Get Instant Access to the Global Irritable Bowel Syndrome (IBS) Treatment Market Report with Swift Delivery!
How Are the Key Segments of the Irritable Bowel Syndrome (IBS) Treatment Market Driving Opportunities and Innovations?
The irritable bowel syndrome (IBS) treatment market covered in this report is segmented –
1) By Drug Type: Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs
2) By Indication: IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea
3) By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies
4) By End-Users: Hospitals, Clinics, Homecare Settings
Subsegments:
1) By Lubiprostone: Chronic Idiopathic Constipation Treatment, Irritable Bowel Syndrome with Constipation (IBS-C) Treatment
2) By Linaclotide: IBS-C Treatment, Chronic Idiopathic Constipation Treatment
3) By Eluxadoline: IBS with Diarrhea (IBS-D) Treatment
4) By Rifaximin: IBS-D Treatment, Small Intestinal Bacterial Overgrowth (SIBO) Treatment
5) By Alosetron: Severe IBS-D Treatment for Women
6) By Other Drugs: Prucalopride, Tenapanor, Plecanatide
Which Geographical Regions Are Pioneering Growth in the Irritable Bowel Syndrome (IBS) Treatment Market?
North America was the largest region in the irritable bowel syndrome (IBS) treatment market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the irritable bowel syndrome (IBS) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Characteristics That Define the Irritable Bowel Syndrome (IBS) Treatment Market?
Irritable bowel syndrome (IBS) treatment refers to the various approaches and interventions aimed at treating gastrointestinal tract disorders, which are frequent disorders that affect the stomach and intestines. It is used to alleviate constipation, diarrhea, and abdominal symptoms, minimize the frequency and severity of flare-ups, and enhance overall well-being.
Browse Through More Similar Reports By The Business Research Company:
Aerospace Interior Adhesive Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/aerospace-interior-adhesive-global-market-report
Aerospace Plastics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/aerospace-plastics-global-market-report
Aerospace Coatings Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/aerospace-coatings-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
